Intradermal delivery of a fractional dose of influenza H7N9 split vaccine elicits protective immunity in mice and rats

References

• Iuliano AD JY, Jones J, Davis CT, Wentworth DE, Uyeki TM, Roguski K, Thompson MG, Gubareva L, Fry AM, et al. Increase in human infections with avian influenza A(H7N9) virus during the fifth epidemic—China, October 2016–February 2017. MMWR Morb Mortal Wkly Rep. 2017;66:254–5. doi:10.15585/mmwr.mm6609e2.
   PubMed Web of Science ®Google Scholar
• Duan Y GH, Chen R, Zhao Z, Zhang L, Xing L, Lai C, Zhang P, Li Z, Zhang K, et al. Response of Mice and Ferrets to a Monovalent Influenza A (H7N9) Split Vaccine. PLOS one. 2014;9:e99322. doi:10.1371/journal.pone.0099322.
   Google Scholar
• Levine MM. Can needle-free administration of vaccines become the norm in global immunization? Na Med. 2003;9:99–103. doi:10.1038/nm0103-99.
   PubMed Web of Science ®Google Scholar
• Saitoh A, Aizawa Y. Intradermal vaccination for infants and children. Hum Vaccines Immunother. 2016;12:2447–55. doi:10.1080/21645515.2016.1176652.
   PubMed Web of Science ®Google Scholar
• Kenney RT FS, Muenz LR, Villar CP, Glenn GM. Dose Sparing with Intradermal Injection of Influenza Vaccine. N Engl J Med. 2004;351:2295–301. doi:10.1056/NEJMoa043540.
   PubMed Web of Science ®Google Scholar
• Elsa E, Kis GW JM. Devices for intradermal vaccination. Vaccine. 2012;30:523–38. doi:10.1016/j.vaccine.2011.11.020.
   PubMed Web of Science ®Google Scholar
• Darius Soonawalaa PVC, Alienke J, Wijmenga-Monsuurb Claire J, Boogb C, Patrick Koedamd Leo G, Vissera Nynke Y. Rotsb. Intradermal fractional booster dose of inactivated poliomyelitis vaccine with a jet injector in healthy adults. Vaccine. 2013;6.
   Google Scholar
• Anthony ES, Nelsona HSL KCC, Wendy CS, Hoc LW, Eva Funga, Frankie WT, Chenga Rita YT, Sunga Michael Royalsd Paul KS. Chanc. A pilot randomized study to assess immunogenicity, reactogenicity,safety and tolerability of two human papillomavirus vaccinesadministered intramuscularly and intradermally to females aged18–26 years. Vaccine. 2013;31:3452. doi:10.1016/j.vaccine.2013.06.034.
   PubMed Web of Science ®Google Scholar
• Mohammed AJ AS, Bawikar S, Kurup PJ, Elamir E, Shaban MMA, Sharif SM, van der Avoort HG, Pallansch MA, Malankar P, et al. Fractional Doses of Inactivated Poliovirus Vaccine in Oman. N Engl J Med. 2010;362:2351–9. doi:10.1056/NEJMoa0909383.
   PubMed Web of Science ®Google Scholar
• Resik S TA, Sutter RW, Diaz M, Sarmiento L, Alemañi N, Garcia G, Fonseca M, Hung LH, Kahn AL, et al. Priming after a Fractional Dose of Inactivated Poliovirus Vaccine. N Engl J Med. 2013;368:416–24. doi:10.1056/NEJMoa1202541.
   PubMed Web of Science ®Google Scholar
• Li N PL-H, Chen X, Nakagawa S, Gao J-Q. Transcutaneous vaccines: Novel advances in technology and delivery for overcoming the barriers. Vaccine. 2011;29:6179–90. doi:10.1016/j.vaccine.2011.06.086.
   PubMed Web of Science ®Google Scholar
• Bal SM DZ, van Riet E, Jiskoot W, Bouwstra JA. Advances in transcutaneous vaccine delivery: Do all ways lead to Rome? J Controll Release. 2010;148:266–82. doi:10.1016/j.jconrel.2010.09.018.
   PubMed Web of Science ®Google Scholar
• James J, Norman JG, Samirkumar R, Patel Sara Park, Courtney Jarrahian, Darin Zehrung, et al. Reliability and accuracy of intradermal injection by Mantoux technique, hypodermic needle adapter, and hollow microneedle in pigs. Drug Deliv and Transl Res. 2014;4:4.
   PubMed Web of Science ®Google Scholar
• Brandtzaeg P ea. Induction of secretory immunity and memory at mucosal surfaces. Vaccine. 2007;25:5467–84. doi:10.1016/j.vaccine.2006.12.001.
   PubMed Web of Science ®Google Scholar
• Zhang X CN, Lemoine S, Mozeleski B, Azria E, Ray CL, Schwartz O, Launay O, Leclerc C, Lo-Man R. Plasmacytoid DC engagement by Flu vaccine as a surrogate strategy for driving Th1 responses in human neonatal settings. J Infect Dis. 2014;210:424–34. doi:10.1093/infdis/jiu103.
   PubMed Web of Science ®Google Scholar
• Belshe RB, Newman FK, Cannon J, Duane C, Treanor J, Van Hoecke C Howe BJ, Dubin G. Serum antibody responses after intradermal vaccination against influenza. N Engl J Med. 2004;351:2286–94. doi:10.1056/NEJMoa043555.
   PubMed Web of Science ®Google Scholar
• Gartlan. KH WJ, Demaria1 MC, Nastovska R, Chang T, L.Jones E, Apostolopoulos V, Pietersz GA, Hickey MJ, van Spriel AB, et al. Tetraspanin CD37 contributes to the initiation of cellular immunity by promoting dendritic cell migration. Eur J Immunol. 2013;43:1208–19. doi:10.1002/eji.201242730.
   PubMed Web of Science ®Google Scholar
• Leroux-Roels I WF. Intanza® 9 µg intradermal seasonal influenza vaccine for adults 18 to 59 years of age. Hum Vaccines Immunother. 2013;9:115–21. doi:10.4161/hv.22342.
   PubMed Web of Science ®Google Scholar
• Atmar RL, Patel SM, Keitel WA. Intanza((R)): a new intradermal vaccine for seasonal influenza. Expert Rev Vaccines. 2010;9:1399–409. doi:10.1586/erv.10.134.
   PubMed Web of Science ®Google Scholar
• Elnekave M, Furmanov K, Hovav AH. Intradermal naked plasmid DNA immunization: mechanisms of action. Expert Rev Vaccines. 2011;10:1169–82. doi:10.1586/erv.11.66.
   PubMed Web of Science ®Google Scholar
• Andrianov AK MG. Intradermal immunization using coated microneedles containing an immunoadjuvant. Vaccine. 2012;30:4355–60. doi:10.1016/j.vaccine.2011.09.062.
   PubMed Web of Science ®Google Scholar
• Skountzou I, Compans RW. Skin immunization with influenza vaccines. Curr Top Microbiol Immunol. 2015;386:343–69.
   PubMed Web of Science ®Google Scholar
• Tuan-Mahmood TM, McCrudden MT, Torrisi BM, McAlister E, Garland MJ, Singh TR, et al. Microneedles for intradermal and transdermal drug delivery. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 2013;50:623–37. doi:10.1016/j.ejps.2013.05.005.
   PubMed Web of Science ®Google Scholar
• Obeid M FJ, Lorthiois A, Gego A, Grüner AC, Tefit M, Boucheix C, Snounou G, Mazier D. Skin draining lymph node priming is sufficient to induce sterile immunity against pre erythrocytic malaria. EMBO Mol Med. 2013;5:250–63. doi:10.1002/emmm.201201677.
   PubMed Web of Science ®Google Scholar
• Weissmueller NT SH, Pollard AJ. Intradermal powder immunization with protein-containing vaccines. Expert Rev Vaccines. 2013;12:687–702. doi:10.1586/erv.13.48.
   PubMed Web of Science ®Google Scholar
• Yu S TC, Shi X, Yang P, Xing L, Wang X. Novel Th1-biased adjuvant, SPO1, enhances mucosal and systemic immunogenicity of vaccines administered intranasally in mice. Vaccine. 2012;30:5425–36. doi:10.1016/j.vaccine.2012.05.085.
   PubMed Web of Science ®Google Scholar
• Kalluri H KC, Banga AK. Characterization of Microchannels Created by Metal Microneedles: Formation and Closure. AAPS Journal. 2011;13:473–81. doi:10.1208/s12248-011-9288-3.
   PubMed Web of Science ®Google Scholar
• Harvey R WJ, Wallis CL, Robertson JS, Engelhardt OG. Quantitation of haemagglutinin in H5N1 influenza viruses reveals low haemagglutinin content of vaccine virus NIBRG-14 (H5N1). Vaccine. 2008 26:6550–4. doi:10.1016/j.vaccine.2008.09.050.
   PubMed Web of Science ®Google Scholar
• H. DJ GW, O. CH. Methods for the study of irritation and toxicity of substances applied topically to the skin and the mucous membranes. J Pharmacol Exp Ther. 1944;82(3): 377–390.
   Google Scholar
• Cao. RG SN, Obermoser G, Lopez SMC, Flano E, Mertz SE, Albrecht RA, García-Sastre A, Mejias A, Xu H, et al. Differences in Antibody Responses between TIV and LAIV Influenza Vaccines Correlate with the Kinetics and Magnitude of Interferon Signaling in Children. J Infect Dis. 2014;210:224–33. doi:10.1093/infdis/jiu079.
   PubMed Web of Science ®Google Scholar